Intensity Therapeutics, Inc. (INTS)
NASDAQ·Healthcare·Biotechnology
$2.80
-6.67%
Mkt Cap $14.65M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$11.00
Range $7.00 – $15.00
Implied Upside
+292.9%
Consensus $11.00 vs current $2.80
NASDAQ·Healthcare·Biotechnology
$2.80
-6.67%
Mkt Cap $14.65M
No recent rating data.
Price Target (3 analysts)
$11.00
Range $7.00 – $15.00
+292.9%
Consensus $11.00 vs current $2.80